Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.844 SEK | +1.69% | -6.01% | -4.09% |
Feb. 27 | Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 21.03M 225M |
---|---|---|---|---|---|
Net income 2021 | -31M -332M | Net income 2022 | -13M -139M | EV / Sales 2021 | - |
Net cash position 2021 | 16.42M 176M | Net cash position 2022 | 13.58M 145M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.15
x | P/E ratio 2022 |
-1.31
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 57.98% |
1 day | +1.69% | ||
1 week | -6.01% | ||
Current month | -12.81% | ||
1 month | -5.59% | ||
3 months | -13.17% | ||
6 months | +16.57% | ||
Current year | -4.09% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Nordkild
CEO | Chief Executive Officer | 69 | 15-12-31 |
Director of Finance/CFO | 69 | 17-03-31 | |
Public Communications Contact | 62 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul de Potocki
CHM | Chairman | 62 | 17-12-31 |
Public Communications Contact | 62 | 10-12-31 | |
Marianne Kock
BRD | Director/Board Member | 69 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.844 | +1.69% | 28,940 |
24-05-16 | 0.83 | -1.43% | 7,255 |
24-05-15 | 0.842 | +0.24% | 10,734 |
24-05-14 | 0.84 | +0.96% | 16,216 |
24-05-13 | 0.832 | -7.35% | 30,709 |
Delayed Quote Nasdaq Stockholm, May 17, 2024 at 10:41 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-4.09% | 1.76M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- ASAP Stock